BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 27465886)

  • 1. Tumor-Infiltrated Lymphocytes, Macrophages, and Dendritic Cells in Endometrioid Adenocarcinoma of Corpus Uteri as Potential Prognostic Factors: An Immunohistochemical Study.
    Zinovkin D; Pranjol MZ
    Int J Gynecol Cancer; 2016 Sep; 26(7):1207-12. PubMed ID: 27465886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-associated macrophages correlate with progesterone receptor loss in endometrial endometrioid adenocarcinoma.
    Jiang XF; Tang QL; Li HG; Shen XM; Luo X; Wang XY; Lin ZQ
    J Obstet Gynaecol Res; 2013 Apr; 39(4):855-63. PubMed ID: 23106983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-infiltrating dendritic cells may be used as clinicopathologic prognostic factors in endometrial carcinoma.
    Lijun Z; Xin Z; Danhua S; Xiaoping L; Jianliu W; Huilan W; Lihui W
    Int J Gynecol Cancer; 2012 Jun; 22(5):836-41. PubMed ID: 22617481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-Associated T-Lymphocytes and Macrophages are Decreased in Endometrioid Endometrial Carcinoma with MELF-Pattern Stromal Changes.
    Zinovkin DA; Pranjol MZI; Bilsky IA; Zmushko VA
    Cancer Microenviron; 2018 Dec; 11(2-3):107-114. PubMed ID: 30008066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic Association and Prognostic Value of Microcystic, Elongated, and Fragmented (MELF) Pattern in Endometrial Endometrioid Carcinoma.
    Kihara A; Yoshida H; Watanabe R; Takahashi K; Kato T; Ino Y; Kitagawa M; Hiraoka N
    Am J Surg Pathol; 2017 Jul; 41(7):896-905. PubMed ID: 28418994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratumoral CD8+ T lymphocytes as a prognostic factor of survival in endometrial carcinoma.
    Kondratiev S; Sabo E; Yakirevich E; Lavie O; Resnick MB
    Clin Cancer Res; 2004 Jul; 10(13):4450-6. PubMed ID: 15240536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of immune microenvironment in laryngeal and pharyngeal squamous cell carcinoma: Immune cell subtypes, immuno-suppressive pathways and clinicopathologic characteristics.
    Karpathiou G; Casteillo F; Giroult JB; Forest F; Fournel P; Monaya A; Froudarakis M; Dumollard JM; Prades JM; Peoc'h M
    Oncotarget; 2017 Mar; 8(12):19310-19322. PubMed ID: 28038471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoexpression of B7-H3 in endometrial cancer: relation to tumor T-cell infiltration and prognosis.
    Brunner A; Hinterholzer S; Riss P; Heinze G; Brustmann H
    Gynecol Oncol; 2012 Jan; 124(1):105-11. PubMed ID: 21982044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Apoptosis and expression of Fas/FasL in tumor infiltrating dendritic cells in human endometrioid adenocarcinoma].
    Jia JJ; Wang ZN; Liu GX; Wang ZX
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Oct; 31(10):1693-6. PubMed ID: 22027769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influences of uterine adenomyosis on muscle invasion and prognosis of endometrioid adenocarcinoma.
    Taneichi A; Fujiwara H; Takahashi Y; Takei Y; Machida S; Saga Y; Takahashi S; Suzuki M
    Int J Gynecol Cancer; 2014 Oct; 24(8):1429-33. PubMed ID: 25188882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infiltration of colorectal carcinoma by S100+ dendritic cells and CD57+ lymphocytes as independent prognostic factors after radical surgical treatment.
    Liska V; Vycital O; Daum O; Novak P; Treska V; Bruha J; Pitule P; Holubec L
    Anticancer Res; 2012 May; 32(5):2129-32. PubMed ID: 22593500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic implication of programmed cell death 1 protein and its ligand expressions in endometrial cancer.
    Kim J; Kim S; Lee HS; Yang W; Cho H; Chay DB; Cho SJ; Hong S; Kim JH
    Gynecol Oncol; 2018 May; 149(2):381-387. PubMed ID: 29572029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Wnt7a is associated with tumor progression and unfavorable prognosis in endometrial cancer.
    Liu Y; Meng F; Xu Y; Yang S; Xiao M; Chen X; Lou G
    Int J Gynecol Cancer; 2013 Feb; 23(2):304-11. PubMed ID: 23321718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B7-H4 (DD-O110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration.
    Miyatake T; Tringler B; Liu W; Liu SH; Papkoff J; Enomoto T; Torkko KC; Dehn DL; Swisher A; Shroyer KR
    Gynecol Oncol; 2007 Jul; 106(1):119-27. PubMed ID: 17509674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor size: a better independent predictor of distant failure and death than depth of myometrial invasion in International Federation of Gynecology and Obstetrics stage I endometrioid endometrial cancer.
    Chattopadhyay S; Cross P; Nayar A; Galaal K; Naik R
    Int J Gynecol Cancer; 2013 May; 23(4):690-7. PubMed ID: 23518862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphological characteristics and co-stimulatory molecule (CD80, CD86, CD40) expression in tumor infiltrating dendritic cells in human endometrioid adenocarcinoma.
    Jia J; Wang Z; Li X; Wang Z; Wang X
    Eur J Obstet Gynecol Reprod Biol; 2012 Feb; 160(2):223-7. PubMed ID: 22142817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of CD3+ tumor-infiltrating lymphocytes in patients with endometrial carcinoma.
    Čermáková P; Melichar B; Tomšová M; Zoul Z; Kalábová H; Spaček J; Doležel M
    Anticancer Res; 2014 Oct; 34(10):5555-61. PubMed ID: 25275055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inverse correlation between tumoral indoleamine 2,3-dioxygenase expression and tumor-infiltrating lymphocytes in endometrial cancer: its association with disease progression and survival.
    Ino K; Yamamoto E; Shibata K; Kajiyama H; Yoshida N; Terauchi M; Nawa A; Nagasaka T; Takikawa O; Kikkawa F
    Clin Cancer Res; 2008 Apr; 14(8):2310-7. PubMed ID: 18413819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Potential Roles of MELF-Pattern, Microvessel Density, and VEGF Expression in Survival of Patients with Endometrioid Endometrial Carcinoma: A Morphometrical and Immunohistochemical Analysis of 100 Cases.
    Zinovkin DA; Pranjol MZI; Petrenyov DR; Nadyrov EA; Savchenko OG
    J Pathol Transl Med; 2017 Sep; 51(5):456-462. PubMed ID: 28934825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting Lymph Node Metastasis in Endometrial Cancer Using Serum CA125 Combined with Immunohistochemical Markers PR and Ki67, and a Comparison with Other Prediction Models.
    Yang B; Shan B; Xue X; Wang H; Shan W; Ning C; Zhou Q; Chen X; Luo X
    PLoS One; 2016; 11(5):e0155145. PubMed ID: 27163153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.